Tyra Biosciences, Inc. Depreciation
Tyra Biosciences, Inc. (TYRA) reported Depreciation of $100.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-05-08
- Tyra Biosciences, Inc. depreciation for the quarter ending 2025-03-31 was $100.00K, a 0.00% change year-over-year.
- Tyra Biosciences, Inc. depreciation for the quarter ending 2024-12-31 was $100.00K, a 0.00% change year-over-year.
- Tyra Biosciences, Inc. depreciation for the quarter ending 2024-09-30 was $100.00K, a 0.00% change year-over-year.
- Tyra Biosciences, Inc. depreciation for the quarter ending 2024-06-30 was $100.00K, a 0.00% change year-over-year.
- Tyra Biosciences, Inc. depreciation for fiscal 2024 was $500.00K, a 25.00% increase from fiscal 2023.
- Tyra Biosciences, Inc. depreciation for fiscal 2023 was $400.00K, a 33.33% increase from fiscal 2022.
- Tyra Biosciences, Inc. depreciation for fiscal 2022 was $300.00K, a 114.29% increase from fiscal 2021.
- Tyra Biosciences, Inc. depreciation for fiscal 2021 was $140.00K, a 197.87% increase from fiscal 2020.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-08 | $200.00K derived: sum of 2 quarters · filed 2025-05-08 | $300.00K derived: sum of 3 quarters · filed 2025-05-08 | $400.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $200.00K derived: sum of 2 quarters · filed 2025-03-27 | $300.00K derived: sum of 3 quarters · filed 2025-03-27 | $500.00K 10-K · filed 2025-03-27 | ||||
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-07 | $200.00K derived: sum of 2 quarters · filed 2024-11-07 | $400.00K 10-Q · filed 2024-11-07 | $400.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-07 | $200.00K 10-Q · filed 2024-08-07 | $300.00K derived: sum of 3 quarters · filed 2025-05-08 | $400.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2024-03-31 | $100.00K 10-Q · filed 2025-05-08 | $200.00K derived: sum of 2 quarters · filed 2025-05-08 | $300.00K derived: sum of 3 quarters · filed 2025-05-08 | $400.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $200.00K derived: sum of 2 quarters · filed 2025-03-27 | $300.00K derived: sum of 3 quarters · filed 2025-03-27 | $400.00K 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-07 | $200.00K derived: sum of 2 quarters · filed 2024-11-07 | $300.00K 10-Q · filed 2024-11-07 | $400.00K derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-07 | $200.00K 10-Q · filed 2024-08-07 | $300.00K derived: sum of 3 quarters · filed 2024-08-07 | $400.00K derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-09 | $83.00K 10-Q · filed 2023-05-04 | $200.00K derived: sum of 2 quarters · filed 2024-05-09 | $300.00K derived: sum of 3 quarters · filed 2024-05-09 | $400.00K derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $200.00K derived: sum of 2 quarters · filed 2024-03-19 | $300.00K derived: sum of 3 quarters · filed 2024-03-19 | $300.00K 10-K · filed 2024-03-19 | $296.00K 10-K · filed 2023-03-22 | |||
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-07 | $82.00M 10-Q · filed 2022-11-03 | $200.00K derived: sum of 2 quarters · filed 2023-11-07 | $200.00K 10-Q · filed 2023-11-07 | $214.00M 10-Q · filed 2022-11-03 | -$89.60M derived: sum of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-10 | $69.00M 10-Q · filed 2022-08-04 | $100.00K 10-Q · filed 2023-08-10 | $132.00M 10-Q · filed 2022-08-04 | -$89.70M derived: sum of 3 quarters · filed 2023-08-10 | -$48.70M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $64.00K 10-Q · filed 2023-05-04 | $64.00M 10-Q · filed 2022-05-05 | -$89.80M derived: sum of 2 quarters · filed 2023-05-04 | -$48.80M derived: sum of 3 quarters · filed 2023-05-04 | -$22.80M derived: sum of 4 quarters · filed 2023-05-04 | |||
| 2021-12-31 | -$89.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$48.86M derived: sum of 2 quarters · filed 2023-03-22 | -$22.86M derived: sum of 3 quarters · filed 2023-03-22 | $140.00K 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | $41.00M 10-Q · filed 2022-11-03 | $67.00M derived: sum of 2 quarters · filed 2022-11-03 | $90.00M 10-Q · filed 2022-11-03 | $61.05M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $26.00M 10-Q · filed 2022-08-04 | $49.00M 10-Q · filed 2022-08-04 | $20.05M derived: sum of 3 quarters · filed 2022-08-04 | $36.05M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $22.00M 10-Q · filed 2022-05-05 | -$5.95M derived: sum of 2 quarters · filed 2022-05-05 | $10.05M derived: sum of 3 quarters · filed 2022-05-05 | |||||
| 2020-12-31 | -$27.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$11.95M derived: sum of 2 quarters · filed 2022-03-03 | $47.00K 10-K · filed 2022-03-03 | |||||
| 2020-09-30 | $16.00M 10-Q · filed 2021-11-03 | $28.00M 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |